Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF SEPTEMBER 07, 2018 FBO #6132
SPECIAL NOTICE

A -- Intent to Sole Source - Modeling Sex-Specific Radiation and Chemotherapy Responses in a Bone Marrow Chip Research

Notice Date
9/5/2018
 
Notice Type
Special Notice
 
NAICS
541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
 
Contracting Office
Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services - Jefferson, 3900 NCTR Road, HFT-320, Bldg 50 | Rm 421, Jefferson, Arkansas, 72079, United States
 
ZIP Code
72079
 
Solicitation Number
FDA-1201756
 
Archive Date
9/25/2018
 
Point of Contact
Jennifer L. Johnson, Phone: 8705437830
 
E-Mail Address
jennifer.johnson3@fda.hhs.gov
(jennifer.johnson3@fda.hhs.gov)
 
Small Business Set-Aside
N/A
 
Description
The U.S. Food and Drug Administration (FDA) intends to award a sole source, cost reimbursement, no fee contract to President and Fellows of Harvard College, 25 Shattuck Street, Boston MA 02115-6027, under the authority of FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. President and Fellows of Harvard College will provide Modeling Sex-Specific Radiation and Chemotherapy Responses in a Bone Marrow Chip Research for the U.S. FDA, Office of the Chief Scientist, Office of Counterterrorism and Emerging Threats (OCET). OCET has determined current research in relation to the "Organ-on-Chips Tools for Testing of Radiation Countermeasures" is a direct follow-on to the existing protocol and must utilize the same equipment (Organ Chips), protocols, procedures, and expertise in order to ensure that results are comparable with the body of work currently being performed; ensuring consistency and integrity of the overall study. This notice is being published in accordance with Federal Acquisition Regulation (FAR) Part 5.101(a)(2) requiring the dissemination of information on proposed contract actions. This is a notice of intent to award a sole-source contract and is not a request for competitive proposals. The statutory authority for this sole-source procurement is FAR 6.302-1. This notice of intent is not a request for competitive proposals. Interested parties that believes it can meet the requirement, may submit a capability statement to Mrs. Jennifer Johnson at jennifer.johnson3@fda.hhs.gov before September 10, 2018 at 12:00 pm Central Standard Time (CST). A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. If no responsive statements are received before the closing date and time, an award will subsequently be made to President and Fellows of Harvard College. No telephonic inquiries.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/NCTR/FDA-1201756/listing.html)
 
Place of Performance
Address: US Food & Drug Administration -- OC, ATTN: To be provided upon contract award, 10903 New Hampshire Ave., Bldg. 32, Silver Spring, Maryland, 20993, United States
Zip Code: 20993
 
Record
SN05073780-W 20180907/180905231422-275680b0d2fab6754aa395ee0f3be702 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.